Cytokinetics, Incorporated (CYTK) Financials

CYTK Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 824.3 million 1.2 billion
2023-09-30 740.6 million 1.2 billion
2023-06-30 779.9 million 1.1 billion
2023-03-31 889.8 million 1.1 billion

CYTK Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -74.1 million 19.5 million
2023-09-30 -96.4 million 18.7 million
2023-06-30 -122.5 million 18.7 million
2023-03-31 -122.7 million 15.2 million

CYTK Net Income

No data available :(

CYTK Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 615.2 million - 138.3 million
2023-09-30 539.2 million - 139.5 million
2023-06-30 565.7 million - 139.5 million
2023-03-31 664.0 million 64.1 million 139.6 million

CYTK Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 99.1 million
2023-09-30 96.1 million
2023-06-30 95.8 million
2023-03-31 95.2 million

CYTK Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 77000 78.6 million 44.1 million -
2023-09-30 220000 378000 40.1 million -
2023-06-30 717000 867000 39.7 million -
2023-03-31 402000 2.1 million 49.7 million -

CYTK Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.7 million 6.3 million
2023-09-30 378000 82.5 million
2023-06-30 867000 83.2 million
2023-03-31 4.6 million 79.4 million

CYTK

Price: $63.37

52 week price:
25.98
110.25

Payout Ratio Range:
-6.49%
-4.63%

Earnings Per Share: -5.45 USD

P/E Ratio: -14.75

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 998300

Ebitda: -35.8 million

Market Capitalization: 7.1 billion

Links: